The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| NLM Information Resource Grants to Reduce Health Disparities (G08) |
93.879 |
RFA-LM-14-001 |
| Pharmacokinetic/Pharmacodynamic (PK/PD) Studies of Methylphenidate Extended Release Products in Attention Deficit Hyperactivity Disorder (ADHD) Patients (U01) |
93.103 |
RFA-FD-14-015 |
| Effect of Therapeutic Class on Generic Drug Substitutions (U01) |
93.103 |
RFA-FD-14-014 |
| Post-market surveillance evaluation of authorized generic drug products (U01) |
93.103 |
RFA-FD-14-013 |
| Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50) |
93.853 |
RFA-NS-14-003 |
| OVW FY 2014 Violence Against Women Bakken Region Initiative: Enhanced Response to Victims |
16.589 |
OVW-2014-3892 |
| OVW FY 2014 Violence Against Women Bakken Region Initiative: Tribal Special Assistant U.S. Attorney |
16.589 |
OVW-2014-3893 |
| HIV/AIDS Initiative for Minority Men (AIMM) |
93.137 |
MP-CPI-14-002 |
| Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (U01) |
93.847 |
RFA-DK-14-003 |
| Epidemiology and Prevention in Alcohol Research (R01) |
93.273 |
PA-14-190 |
| Epidemiology and Prevention in Alcohol Research (R03) |
93.273 |
PA-14-189 |
| Epidemiology and Prevention in Alcohol Research (R21) |
93.273 |
PA-14-188 |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21) |
93.846 |
PAR-14-192 |
| Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30) |
93.859 |
PAR-14-178 |
| National Center for Legal and Judicial Excellence in Child Welfare |
93.670 |
HHS-2014-ACF-ACYF-CZ-0807 |
| Family Self-Sufficiency Program Coordinators |
14.896 |
FR-5800-N-08 |
| SMART FY Campus Sexual Assault Perpetrator Treatment Pilot Project |
16.203 |
SMART-2014-3915 |
| NEI Audacious Goal Initiative: Addressing Technical Needs and Opportunities for Imaging the Visual System (U01) |
93.867 |
RFA-EY-14-001 |
| Revision Applications for NIDCR-funded Cooperative Agreements (U01) |
93.121 |
PAR-14-187 |
| NIDA Core "Center of Excellence" Grant Program (P30) |
93.279 |
PAR-14-186 |
| Agricultural, Forestry and Fishing Safety and Health Research |
93.262 |
PAR-14-175 |
| Targeting Co-dependent Molecular Pathways in Oral Cancer (U01) |
93.121 |
RFA-DE-15-004 |
| Enabling Resources for Pharmacogenomics (R24) |
93.859 |
PAR-14-185 |
| Strategies to Increase Residential Energy Code Compliance Rates and Measure Results |
81.086 |
DE-FOA-0000953 |
| National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01) |
93.242, 93.273, 93.279 |
PAR-14-184 |
| NINDS Program Project Grant (P01) |
93.853 |
PAR-14-183 |
| NIJ FY 14 Methodological Research to Support NIJ's Program of Research Examining Violence and Victimization of American Indian (AI) and Alaska Native (AN) Youth |
16.560 |
NIJ-2014-3897 |
| Prospective Studies on the Impact of Generic Immunosuppressants on Acute Rejection and Long Term Graft survivals (U01) |
93.103 |
RFA-FD-14-020 |
| Pharmacokinetic and Pharmacodynamic (PK-PD) Studies of Cardiovascular Drugs (U01) |
93.103 |
RFA-FD-14-024 |
| The Effect of Different Preparation Methods on the In Vitro and In Vivo Performance of Solid Dispersion Formulations (U01) |
93.103 |
RFA-FD-14-023 |
| Retrospective Analysis on the Impact of Generic Immunosuppressants on Acute Rejection and Long Term Graft Survivals (U01) |
93.103 |
RFA-FD-14-021 |
| Evalution of Iron Species in Healthy Subjects treated with Generic and Reference Sodium Ferric Gluconate |
93.103 |
RFA-FD-14-019 |
| Exploratory Clinical Trials of Mind and Body Interventions for NCCAM High Priority Research Topics (R34) |
93.213 |
PAR-14-182 |
| Undiagnosed Diseases Gene Function Research (R21) |
93.310 |
RFA-RM-14-005 |
| mHealth Tools for Underserved Populations with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R21) |
93.286, 93.361 |
PA-14-181 |
| mHealth Tools for Underserved Populations with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R01) |
93.286, 93.361 |
PA-14-180 |
| Collaborations to Improve Identification and Care for Chronic Hepatitis B Virus (HBV) Infection among Persons in the United States who were Born in Countries with Intermediate-High (greater than or equal to two percent) |
93.270 |
CDC-RFA-PS14-1414 |
| NIJ FY 14 Online Flight Data and Incident Reporting System for Public Safety Use of Small Unmanned Aircraft Systems (sUAS) |
16.560 |
NIJ-2014-3793 |
| Clinical Trial Planning Grant for Interventions and Services to Improve Treatment and Prevention of HIV/AIDS (R34) |
93.242, 93.855, 93.856 |
PA-14-179 |
| Development of realistic in vitro studies to assess robustness of dose counters/indicators in metered dose inhalers (U01) |
93.103 |
RFA-FD-14-025 |
Search Results 10361-10400 of 17642
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 [Next] |
